Wei-Wei Deng (Weiwei Deng)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Randomized Controlled Trial

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Si-Rui Ma, Jian-Feng Liu, Rong Jia, Wei-Wei Deng, Jun Jia
Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1 high with CD8/PD-1 high . Biomolecules 13 (6) (2023)
Lei Wu, Yuantong Liu, Wei-Wei Deng, Tianfu Wu, Lin-Lin Bu, Lei Chen
OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC. International journal of molecular sciences 24 (16) (2023)
Si-Rui Ma, Jian-Feng Liu, Rong Jia, Wei-Wei Deng, Jun Jia
Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1 high with CD8/PD-1 high . Biomolecules 13 (6) (2023)
Si-Rui Ma, Jian-Feng Liu, Rong Jia, Wei-Wei Deng, Jun Jia
Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1 high with CD8/PD-1 high . Biomolecules 13 (6) (2023)